Based on the revenues gained from surgical imaging products, the overall surgical imaging market is dominated by four major players contributing to approximately 74% of the surgical imaging market. These players include GE Healthcare (U.K.), Siemens AG (Germany), Philips (Netherlands) and Ziehm Imaging (Germany).

The global surgical imaging market is witnessing a moderate growth and will continue to do so in the next five years. The factors contributing to the growth of this market include the growing preference of minimally invasive surgeries, rise in aging population and the rising prevalence of cardiovascular diseases. The Asian region is projected to grow at the highest CARG with growth hinged at China and India.

The market growth in the North American region, comprising of U.S. and Canada, is primarily driven by increased adoption of the surgical imaging equipment. Funding by government and private organizations in the purchase of this equipment has further fortified the adoption trend. Increase in adoption of mobile C-arms amongst hospitals contributes to the growth of the European market. The RoW market is expected to witness some growth as well. This growth can be attributed to the availability of funding for the purchase of surgical imaging equipment here.

The leading position of GE Healthcare can be attributed to its strong product portfolio, which includes its flagship product, OEC 9900 Elite. The OEC 9900 Elite provides improved image quality and optimal dose management. This translates to improved patient care. In November 2012, the company launched OEC Brivo 865 Advance, a new mobile C-arm developed as an affordable option for orthopedic surgical imaging. In this manner, the company has developed mobile C-arms to suit every application and price range of their customers. The company has a strong focus on innovation and raising the bar in terms of quality of product delivered. An independent study conducted by University of Texas and presented at the North American Spine Society-2012, rated OEC Elite 9900 as the best in dose management and image quality. These developments in image quality and dose management translate to improved quality of patient care. Furthermore, The company has wide geographic presence in the regions of North America, Europe, Middle East, Africa, Asia-Pacific and Latin America.

Siemens AG and Koninklijke Philips N.V. are the other leadings player in this market. They have a wide portfolio of mobile C-arms and are equipped with both the age old image intensifier and the current flat detector technology. Siemens AG has a strong focus on innovation and gaining FDA approvals. The company’s flag ship mobile C-arm, Cios Alpha and delivers excellent image quality at low dosage. It was the recipient of the iF Product Design Award 2014. Furthermore, Siemens also received FDA approval in April 2014. Koninklijke Philips strategically focuses on high growth markets. Emerging markets such as China and India are of particular interest to Philips and it is taking measures to tap into the huge growth potential in these regions. As of 2013, the company has already established a research and development centre and a manufacturing unit in India to increase its footprint in the growing Indian market. Germany based Ziehm Imaging is one of the fast growing players in the surgical imaging market. The company uses an aggressive expansion strategy to enter new geographies. For instance, in April 2013, Ziehm Medical Shanghai, the company’s subsidiary, opened a new branch office in Guangzhou, China. The new facility is likely to increase the company’s footprint in the Southern Chinese market. The other prominent players in the market include Toshiba Corporation (Japan), Shimadzu Corporation (Japan), Hologic, Inc. (U.S.), OrthoScan (U.S.) and Eurocolumbus (Italy).

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.